AbbVie Inc.Long
$108 By Wednesday
Resistance is being tested as shown by the Kurotoga Cloud. RSI is a low 37.01 indicating that the stock is under bought ahead of earnings.
MACD shows weakening bullish divergence on the 45min candlestick chart, but the 3x confirm shows room for growth.
This is another publication where technicals are thrown out the window due to earnings, but with ABBV being a big pharma company and a history of beating earnings, I feel comfortable with my call for $104 by the end of February.
With an earnings beat, expect to see the stock price hit a minimum of $108 by Wednesday and possibly $112 by the end of the week based off of previous candlestick trends.
MACD shows weakening bullish divergence on the 45min candlestick chart, but the 3x confirm shows room for growth.
This is another publication where technicals are thrown out the window due to earnings, but with ABBV being a big pharma company and a history of beating earnings, I feel comfortable with my call for $104 by the end of February.
With an earnings beat, expect to see the stock price hit a minimum of $108 by Wednesday and possibly $112 by the end of the week based off of previous candlestick trends.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.